A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray
- Conditions
- Skin Care
- Interventions
- Other: Reference productOther: Negative controlOther: Prototype disinfectant spray formulation
- Registration Number
- NCT02106403
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The objective of this randomised, examiner and subject blinded study is to evaluate and compare cooling performance and overall consumer liking of the prototype formulation with the currently marketed wound spray and negative control in subjects with experimental wounds. For each subject, three superficial wounds will be induced on two volar forearms, by sequential tape strippings until a glistening layer is visualized. After wounding, a randomised test product will be sprayed twice on test site, and the subject will be asked to complete a questionnaire evaluating product cooling performance and overall liking.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Participants in good health with healthy and intact skin on the test area
- Age 18-60 years
- Pregnancy or breast-feeding
- Allergy/Intolerance
- Participants currently taking any topical or systemic treatments that may interfere with or mask the test results
- Participants who have taken any topical anti-inflammation treatment in the application area in past 2 months
- Participants who are vulnerable to any intervention
- Damaged skin close to test site, active skin disorders, any visible skin disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Reference product Reference product 0.13% w/w BAC. After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound Negative control Negative control 0.9% w/v sodium chloride solution. After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound Prototype disinfectant spray formulation Prototype disinfectant spray formulation 0.13% w/w Benzalkonium Chloride (BAC) and 1% Menthone Glycerin Acetal (MGA). After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound
- Primary Outcome Measures
Name Time Method Participant-perceived Cooling Sensation at 5 Min At 5 min after product application The cooling sensation was assessed on VAS (0-100 mm, where 0= no cooling and 100= extreme cooling) at 5 min post study product application.
Participant-perceived Cooling Sensation at 15 Min At 15 min after product application The cooling sensation was assessed on VAS (0-100 mm, where 0= no cooling and 100= extreme cooling) at 15 min post study product application.
Participant-perceived Cooling Sensation Immediately Post Product Application Immediately after product application The cooling sensation was assessed immediately after the study product application on 100 millimeter (mm) Visual Analogue Scale (VAS) (0-100 mm, where 0= no cooling and 100= extreme cooling).
Participant-perceived Cooling Sensation at 3 Min At 3 min after product application The cooling sensation was assessed on VAS (0-100 mm, where 0= no cooling and 100= extreme cooling) at 3 min post study product application.
- Secondary Outcome Measures
Name Time Method Overall Sensory Liking of Study Products Immediatey, 3 min, 5 min and 15 min after product application Overall sensory liking of the study products was assessed immediately, 3min, 5 min and 15 min after products application. The assessment was done on a 9 point categorical scale where 1= Dislike it extremely, 2= Dislike it very much, 3= Dislike it moderately, 4= Dislike it slightly, 5= Neither like it nor dislike it, 6= Like it slightly, 7= Like it moderately, 8= Like it very much, 9= Like it extremely.
Trial Locations
- Locations (1)
Guangzhou Landproof Testing Technology Co., LTD
🇨🇳Guangzhou, Guangdong, China